Cargando…

Somatostatin receptor 2 targeting in small cell lung carcinoma: perspectives

Small Cell lung carcinoma (SCLC) is the most lethal and aggressive subtype of lung cancer. Novel targeting approaches and agents are desperately needed. In this perspectives, we briefly explore recent data published in the International Journal of Cancer suggesting Somatostatin Receptor 2 (SSTR2) as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lehman, Jonathan M., aMassion, Pierre P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677662/ https://www.ncbi.nlm.nih.gov/pubmed/31413814 http://dx.doi.org/10.18632/oncotarget.27107

Ejemplares similares

Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy
por: Lapa, Constantin, et al.
Publicado: (2016)

Somatostatin Decorated Quantum Dots for Targeting of Somatostatin Receptors
por: Hafez Abdellatif, Ahmed Abdelfattah, et al.
Publicado: (2018)

Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging
por: Buder, Kristina, et al.
Publicado: (2014)

Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411
por: Holmboe, Sif, et al.
Publicado: (2017)

In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic Target
por: Şen, Feyza, et al.
Publicado: (2023)

Somatostatin Analogues for Receptor Targeted Photodynamic Therapy
por: Kaščáková, Slávka, et al.
Publicado: (2014)

Aberrant Methylation Inactivates Somatostatin and Somatostatin Receptor Type 1 in Head and Neck Squamous Cell Carcinoma
por: Misawa, Kiyoshi, et al.
Publicado: (2015)

Targeting Somatostatin Receptors By Functionalized Mesoporous Silica Nanoparticles - Are We Striking Home?
por: Paramonov, Valeriy M, et al.
Publicado: (2018)

Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm
por: Barbieri, Federica, et al.
Publicado: (2013)

Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome
por: Kiviniemi, Aida, et al.
Publicado: (2017)

Molecular and Clinical Implications of Somatostatin Receptor Profile and Somatostatin Analogues Treatment in Oral Cavity Squamous Cell Carcinoma
por: Sanjuan-Sanjuan, Alba, et al.
Publicado: (2021)

Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System
por: Shamsi, Bilal Haider, et al.
Publicado: (2021)

Somatostatin Receptors as Molecular Targets in Human Uveal Melanoma
por: Harda, Kristof, et al.
Publicado: (2018)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Exploration of Somatostatin Binding Mechanism to Somatostatin Receptor Subtype 4
por: Börzsei, Rita, et al.
Publicado: (2022)

Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer.
por: Macaulay, V. M., et al.
Publicado: (1991)

Somatostatin and the “Small-For-Size” Liver
por: Hessheimer, Amelia J., et al.
Publicado: (2019)

Expression of Somatostatin Receptor 2 in Somatotropinoma Correlated with the Short-Term Efficacy of Somatostatin Analogues
por: Liu, Wenjuan, et al.
Publicado: (2017)

Somatostatin receptor scintigraphy in sarcoidosis
por: Kamphuis, Lieke SJ, et al.
Publicado: (2011)

Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells
por: Rossi, Valentina, et al.
Publicado: (2019)

Evans Blue Attachment Enhances Somatostatin Receptor Subtype-2 Imaging and Radiotherapy
por: Tian, Rui, et al.
Publicado: (2018)

Analysis of somatostatin receptors and somatostatin promoter methylation in human gastric cancer
por: SHI, XUEFEI, et al.
Publicado: (2013)

Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms
por: del Olmo-Garcia, Maria Isabel, et al.
Publicado: (2021)

Membrane-displayed somatostatin activates somatostatin receptor subtype-2 heterologously produced in Saccharomyces cerevisiae
por: Hara, Keisuke, et al.
Publicado: (2012)

Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors
por: Watanabe, Hirofumi, et al.
Publicado: (2022)

Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells
por: Veenstra, Marije J., et al.
Publicado: (2016)

Somatostatin receptors as a new active targeting sites for nanoparticles
por: Abdellatif, Ahmed A.H., et al.
Publicado: (2018)

Inter and intra-tumor somatostatin receptor 2 heterogeneity influences peptide receptor radionuclide therapy response
por: Feijtel, Danny, et al.
Publicado: (2021)

Evaluation of a New (177)Lu-Labeled Somatostatin Analog for the Treatment of Tumors Expressing Somatostatin Receptor Subtypes 2 and 5
por: Mansi, Rosalba, et al.
Publicado: (2020)

Comment on: Somatostatin receptor SPECT
por: Hubalewska-Dydejczyk, Alicja, et al.
Publicado: (2012)

Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.
por: O'Byrne, K. J., et al.
Publicado: (1994)

A new (68)Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting
por: Mansi, Rosalba, et al.
Publicado: (2020)

Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions
por: Heidari, Pedram, et al.
Publicado: (2018)

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
por: Klomp, M.J., et al.
Publicado: (2020)

Somatostatin Receptor-Directed PET/CT for Therapeutic Decision-Making and Disease Control in Patients Affected With Small Cell Lung Cancer
por: Serfling, Sebastian E., et al.
Publicado: (2023)

Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly
por: Venegas‐Moreno, Eva, et al.
Publicado: (2017)

Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids
por: Prasad, Vikas, et al.
Publicado: (2015)

Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets
por: Kaemmerer, Daniel, et al.
Publicado: (2017)

Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report
por: Guida, Michele, et al.
Publicado: (2020)

Targeting of somatostatin receptors expressed in blood cells using quantum dots coated with vapreotide
por: Abdellatif, Ahmed A.H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l3q1rugtjqo27c3uvdvqpj25j9